GlyT1 Assay(s)

Background Information

Sodium-dependent glycine transporter 1 (GlyT1, encoded by SLC6A9) is a transmembrane transporter responsible for the reuptake of glycine, the major inhibitory neurotransmitter in the central nervous system. GlyT1 is a member of the SLC6 family of sodium- and chloride-dependent neurotransmitter transporters. The transporter plays a key role in regulating extracellular glycine concentrations, particularly in glycinergic synapses and in modulating N-methyl-D-aspartate (NMDA) receptor activity through glycine clearance. Dysregulation of GlyT1 function has been implicated in various neurological and psychiatric disorders, including schizophrenia, epilepsy, and cognitive dysfunction. As such, GlyT1 is a promising pharmacological target for the development of novel therapeutics aimed at modulating glycinergic and glutamatergic neurotransmission.

Family: SLC Transporter
Protein Name: GlyT1
Gene Name: SLC6A9

Organism : Human
Therapeutic Area: CNS

Assay Information

Validated Assay(s): Sodium-dependent SLC Transporter Assay, Membrane Potential Assay Potassium Channel Assay
Assay type: Cell-based
Method: Fluorescence

Instrumentation: FLIPR, Panoptic, Flexstation
Plate Format: 96- or 384-well
Expression: Stable
Cell type: HEK293T 

Testing Information

Functional Mode(s): Potentiator, Substrate, Inhibitor
Reference compound(s): Glycine, ALX-5407

Dose response curve for a GlyT1 inhibition assay using a Sodium-dependent SLC Transporter assay and the inhibitor, ALX-5407

Enquire now